Tocqueville Asset Management’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

Tocqueville Asset Management’s Portfolio BLPH Stock Details BLPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-11,600	Closed	-$77K	–	752
2020 Q4	$77K	Sell	11,600 -17,300	-60%	-$142K	﹤0.01%	695
2020 Q3	$294K	Buy	28,900 +3,500	+14%	+$41.2K	0.01%	571
2020 Q2	$319K	Buy	25,400 +14,100	+125%	+$197K	0.01%	552
2020 Q1	$124K	Buy	+11,300	New	+$75.8K	﹤0.01%	613

Other funds holding BLPH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NMVA

New Mountain Vantage Advisers New York $4.33B AUM 35.3% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

CCM

CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tocqueville Asset Management's BLPH Position: Q1 2021 in Review

Tocqueville Asset Management sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q1 2021, closing a stake of 11,600 shares — an estimated $77K sold.

Tocqueville Asset Management first reported a position in BLPH in Q1 2020 and held it in 4 quarters. The position peaked at $319K in Q2 2020. 39 funds tracked by Wall St. Rank hold BLPH as of Q1 2021.

Tocqueville Asset Management reported no remaining Bellerophon Therapeutics, Inc. position as of Q1 2021 after selling out during the quarter.
Tocqueville Asset Management sold 11,600 Bellerophon Therapeutics, Inc. shares in Q1 2021, an estimated $77K.
Tocqueville Asset Management first reported a position in Bellerophon Therapeutics, Inc. in Q1 2020 and held it in 4 quarters.
Tocqueville Asset Management's Bellerophon Therapeutics, Inc. position peaked at $319K in Q2 2020.
39 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q1 2021.

Based on Tocqueville Asset Management's 13F filing for Q1 2021, filed 17 May 2021.